|
|
|
| |
|
Order Now | Back To Index
|
Glyburide
|
|
Pronounced: (GLI-byoor-ide)
Other Names: None Listed
Catagory: Antidiabetic, Sulfonylurea |
|
Top of Page
|
|
Drug InformationThis medicine is used to treat type II diabetes, either alone or in combination with other oral medications.
Mechanism:
Glyburide increases the production of insulin to maintain lower blood glucose levels. Type II diabetics still produce some insulin (not enough to maintain normal blood glucose levels), and glyburide may be used in combination with diet, exercise, weight management, and other oral medications for best control.
More Info:
For more information about this medication, talk to your healthcare provider.
|
|
Top of Page
|
|
Side Effectsweight gain
Precautions:
If the patient then skips the meal, the result can be dangerously low blood sugar, so it is important to maintain a regular eating schedule if taking this medication.
Preganant:
Glyburide is not known to cause birth defects, but the sulfonylurea category is not recommended for use in pregnancy. Use only if clearly needed. It is not known whether glyburide is excreted in breast milk, so caution should be used in deciding whether to discontinue the drug or the breast-feeding.
|
|
Top of Page
|
|
Dosage InformationGlyburide is usually fairly easy on the stomach and is normally taken about 30 minutes before a meal, as a single dose or in divided doses.
Missed Dosage:
Take your next dose as soon as you remember. If it is time for your next dose, skip the missed dose and go back to your regular schedule. Do not double doses.
Storage:
Keep this medication in the container it came in, tightly closed, and out of reach of children. Store it at room temperature and away from excess heat and moisture (not in the bathroom). Throw away any medication that is outdated or no longer needed.
Overdose:
Seek medical attention immediately. For non emergencies, contact your local or regional poison control center at 1-800-222-1222.
|
|
Top of Page
|
|
|
| |
| | | | | | | | Drug Library |
| | |
|
|
|